Long, Georgina V.
Fung, Carina
Menzies, Alexander M.
Pupo, Gulietta M.
Carlino, Matteo S.
Hyman, Jessica
Shahheydari, Hamideh
Tembe, Varsha
Thompson, John F.
Saw, Robyn P.
Howle, Julie
Hayward, Nicholas K.
Johansson, Peter
Scolyer, Richard A.
Kefford, Richard F.
Rizos, Helen
Article History
Received: 9 July 2014
Accepted: 29 October 2014
First Online: 2 December 2014
Competing interests
: A.M.M.-travel Support, GlaxoSmithKline; Honoraria GlaxoSmithKline; M.S.C.-Honoraria GlaxoSmithKline and Novartis; J.F.T.-travel support, GlaxoSmithKline, Provectus; Consultant Advisor-Roche, GlaxoSmithKline, Provectus; Honoraria-GlaxoSmithKline, Provectus; R.F.K.-Consultant Advisor Roche, GlaxoSmithKline and Novartis; R.A.S.-Consultant Advisor Roche, GlaxoSmithKline and Novartis; G.V.L.-Consultant Advisor Roche, GlaxoSmithKline and Novartis; travel support, Roche; Honoraria Roche, GlaxoSmithKline. The remaining authors declare no competing financial interests.